Moderna, Inc. Director NOUBAR B AFEYAN is set to sell 15,000 shares of the company's common stock, with an aggregate market value of approximately $2,068,500, on June 18, 2024. The shares were originally acquired on May 1, 2012, through a private placement from the issuer, with a cash payment. This planned transaction follows a series of sales over the past three months, where a total of 402,832 shares were sold for gross proceeds of $54,707,659.40. The notice of the upcoming sale was filed on the same date as the planned sale, with the initial plan adoption or instruction for the transaction dating back to November 7, 2023.

Moderna, Inc. Director NOUBAR B AFEYAN is set to sell 15,000 shares of the company's common stock, with an aggregate market value of approximately $2,068,500, on June 18, 2024. The shares were originally acquired on May 1, 2012, through a private placement from the issuer, with a cash payment. This planned transaction follows a series of sales over the past three months, where a total of 402,832 shares were sold for gross proceeds of $54,707,659.40. The notice of the upcoming sale was filed on the same date as the planned sale, with the initial plan adoption or instruction for the transaction dating back to November 7, 2023.